Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RGI-2001 for GvHD Prevention in AHSCT
NCT01379209Phase 2Completed
- Sponsor
- REGiMMUNE
- Start
- Sep 2011
- Primary completion
- Jun 2015
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of RGI-2001 in graft-versus-host disease (GVHD), sponsored by REGiMMUNE. Started Sep 2011; status: completed.
02
Drugs
RGI-2001
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT01379209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01379209.